The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement
- PMID: 34451875
- PMCID: PMC8398491
- DOI: 10.3390/ph14080778
The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement
Abstract
Background: The mTOR signaling pathway is inactivated by AMPK's tumor-suppressing function. It is recognized that ubiquitin conjugating enzyme 2O (UBE2O), which directly targets AMPK for ubiquitination and degradation, is intensified in human cancers.
Methods: This study investigated the clinical data about prostate cancer. Examination was also carried out into tissue microarrays (TMA) of human prostate cancer (n = 382) and adjacent non-neoplastic tissues around prostate cancer (n = 61). The TMA slides were incubated with antibodies against UBE2O, and the cores were scored by the pathologist blind to cancer results.
Results: Very strong positive correlations were identified between the expression of UBE2O staining and high PSA and pathological stage of prostate cancer. Cox's proportional hazard analysis established correlations between the following: (1) positive surgical margin and biochemical recurrence free survival, (2) PSA grade and clinical recurrence free survival, (3) regional lymph node positive and clinical recurrence free survival, (4) adjuvant treatment and overall survival, and (5) pathological T stage and overall survival.
Conclusion: There is a positive correlation between the expression of UBE2O staining and prognosis for prostate cancer. Thus, a prostate cancer prognosis can be assessed with the expression of UBE2O staining.
Keywords: UBE2O; prostate cancer; ubiquitin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.J Biol Chem. 2018 Jul 20;293(29):11296-11309. doi: 10.1074/jbc.RA117.001432. Epub 2018 Jun 5. J Biol Chem. 2018. PMID: 29871923 Free PMC article.
-
A new duet in cancer biology: AMPK the typical and UBE2O the atypical.Mol Cell Oncol. 2017 Mar 17;4(3):e1304846. doi: 10.1080/23723556.2017.1304846. eCollection 2017. Mol Cell Oncol. 2017. PMID: 28616582 Free PMC article.
-
UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.Cell Death Dis. 2020 Jan 6;11(1):10. doi: 10.1038/s41419-019-2194-9. Cell Death Dis. 2020. PMID: 31907353 Free PMC article.
-
Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multiprotein complexes for degradation.Turk J Biol. 2022 Feb 24;46(2):186-194. doi: 10.3906/biy-2106-63. eCollection 2022. Turk J Biol. 2022. PMID: 37533513 Free PMC article. Review.
-
The Ubiquitin-Conjugating Enzyme E2 O (UBE2O) and Its Therapeutic Potential in Human Leukemias and Solid Tumors.Cancers (Basel). 2024 Sep 3;16(17):3064. doi: 10.3390/cancers16173064. Cancers (Basel). 2024. PMID: 39272922 Free PMC article. Review.
Cited by
-
The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis.J Cancer Res Clin Oncol. 2023 Aug;149(9):6351-6360. doi: 10.1007/s00432-023-04611-7. Epub 2023 Feb 8. J Cancer Res Clin Oncol. 2023. PMID: 36752909 Free PMC article.
-
Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma.Sci Adv. 2023 Nov 24;9(47):eadi0889. doi: 10.1126/sciadv.adi0889. Epub 2023 Nov 22. Sci Adv. 2023. PMID: 37992172 Free PMC article.
-
Arborinine from Glycosmis parva leaf extract inhibits clear-cell renal cell carcinoma by inhibiting KDM1A/UBE2O signaling.Food Nutr Res. 2022 Sep 16;66. doi: 10.29219/fnr.v66.8714. eCollection 2022. Food Nutr Res. 2022. PMID: 36185617 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous